Pendulum Glucose Control News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN FRANCISCO, June 27, 2023--Pendulum Therapeutics, the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announced today a strategic partnership with New Zealand dairy nutrition company Fonterra. Fonterra will invest $10 million into the growth-stage company to co-develop and commercialize next-generation microbiome products.

San Francisco, California (PRWEB) January 27, 2022 -- Pendulum Therapeutics, a leader in harnessing evidence-based microbiome science and DNA sequencing to

/PRNewswire/ -- Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the...

/PRNewswire/ -- Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the...

Pendulum Therapeutics Raises $54 million Gut health biotech company Pendulum Therapeutics recently announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures. The Series C round nearly doubled the entirety of Pendulum’s previous raises, bringing the total venture capital raised to $111 million. As lead investor, Meritech General Partner Craig Sherman will take a seat on the Pendulum Board of Directors alongside Roelof Botha, a partner at Sequoia, and Adam D�...